Correction: Cytokine Receptor-Like Factor 1 (CRLF1) Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway

by Brendan D. Looyenga, James Resau, Jeffrey P. MacKeigan
Published 2014-01-01

Correction: Cytokine Receptor-Like Factor 1 () Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway.

by Brendan D. Looyenga, James Resau, Jeffrey P. MacKeigan
Published 2014-01-01

Cytokine receptor-like factor 1 (CRLF1) protects against 6-hydroxydopamine toxicity independent of the gp130/JAK signaling pathway.

by Brendan D Looyenga, James Resau, Jeffrey P MacKeigan
Published 2013-01-01

STAT3 is activated by JAK2 independent of key oncogenic driver mutations in non-small cell lung carcinoma.

by Brendan D Looyenga, Danielle Hutchings, Irene Cherni, Chris Kingsley, Glen J Weiss, Jeffrey P Mackeigan
Published 2012-01-01

A Mitochondrial RNAi Screen Defines Cellular Bioenergetic Determinants and Identifies an Adenylate Kinase as a Key Regulator of ATP Levels

by Nathan J. Lanning, Brendan D. Looyenga, Audra L. Kauffman, Natalie M. Niemi, Jessica Sudderth, Ralph J. DeBerardinis, Jeffrey P. MacKeigan
Published 2014-05-01